Bcel stock forecast.

About the Atreca Inc – Class A stock forecast. As of 2023 November 08, Wednesday current price of BCEL stock is 0.290$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).

Bcel stock forecast. Things To Know About Bcel stock forecast.

Atreca (BCEL) Insider Trading Activity 2023. All the trading advice you’ve ever received boils down to this (Ad) How major US stock indexes fared Friday, 12/1/2023. US targets oil and natural gas industry's role in global warming with new rule on methane emissions. S&P 500 4,594.63. DOW 36,245.50.Cymabay Therapeutics Inc () Stock Market info Recommendations: Buy or sell Cymabay Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cymabay Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Cymabay Therapeutics's CBAY shares and potentially …Nov 30, 2023 · 5 equities research analysts have issued twelve-month target prices for Atreca's stock. Their BCEL share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This suggests a possible upside of 4,474.5% from the stock's current price. Atreca Stock Forecast and Price Target. According to six esteemed experts, the average price target for Atreca to reach this year is $17.00, with a potential upside of approximately 1,600%. This prediction is based on a high estimate of $35.00 and a low estimate of $11.00.

The Atreca Inc. stock price gained 5.36% on the last trading day (Friday, 17th Nov 2023), rising from $0.209 to $0.220. During the last trading day the stock fluctuated 9.33% from a day low at $0.210 to a day high of $0.230. The price has been going up and down for this period, and there has been a -16.59% loss for the last 2 weeks.Read more about BCEL’s peers. A high-level overview of Atreca, Inc. (BCEL) stock. Stay up to date on the latest stock price, chart, news, analysis, …Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...

The 360 Finance, Inc. stock price fell by -2.78% on the last day (Wednesday, 22nd Nov 2023) from $16.53 to $16.07. During the last trading day the stock fluctuated 4.68% from a day low at $15.81 to a day high of $16.55. The price has risen in 6 of the last 10 days and is up by 4.15% over the past 2 weeks.Atreca, Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Atreca, Inc. Stock | BCEL | US04965G1094

BCEL Stock 12 Months Forecast. $2.00. (790.87% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Atreca in the last 3 months. The average price target is $2.00 with a high forecast of $2.00 and a low forecast of $2.00. The average price target represents a 790.87% change from the last price of $0.22. Nov 30, 2023 · Read Full Company Summary for BCEL here. View Atreca, Inc BCEL investment & stock information. Get the latest Atreca, Inc BCEL detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. On May 10, 2023, Atreca (NASDAQ:BCEL) announced its financial results for the first quarter of the year. The company reported Atreca Reports Q1 2023 Financial Results with Exceeding Analyst Estimates - Best StocksAtreca Inc Cl A (BCEL) Company Description. Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism ...

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...

April 06, 2023 — 09:55 am EDT. Written by Zacks Equity Research for Zacks ->. Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer ...

Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business.Earnings announcement* for BCEL: Our vendor, Zacks Investment Research, hasn't provided us with the upcoming earnings report date. BCEL has a "high" Earnings Quality Ranking (EQR) for the 5th ... Their VKTX share price targets range from $19.00 to $37.00. On average, they predict the company's stock price to reach $30.25 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price. View analysts price targets for VKTX or view top-rated stocks among Wall Street analysts.About the Atreca Inc – Class A stock forecast. As of 2023 November 08, Wednesday current price of BCEL stock is 0.290$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Atreca Inc - Class A stock price has been showing a declining tendency so we believe that similar market segments were …Find the latest ADMA Biologics, Inc. (ADMA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Stock Target Advisor’s own stock analysis of Atreca Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Atreca Inc’s stock price was USD 0.22. Atreca Inc’s stock price has changed by -5.11% over the past week, +8.25% over the past month and -79.54% over the last year.Nov 6, 2023 · Atreca is forecast to grow earnings and revenue by 10.3% and 9.5% per annum respectively while EPS is expected to grow by 30.2% per annum.

Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business.🚀 Atreca stock price forecast: $4; Market Cap: 11.00M, Enterprise value: 68.43M, P/E: -0.4, PEG ratio: -0.03, EPS: -2.11, Revenue: N/A, EBITDA: -81.73M, Income ...Atreca (BCEL) Insider Trading Activity 2023. All the trading advice you’ve ever received boils down to this (Ad) How major US stock indexes fared Friday, 12/1/2023. US targets oil and natural gas industry's role in global warming with new rule on methane emissions. S&P 500 4,594.63. DOW 36,245.50.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25.Fiscal Q3 2023 ended 9/30/23. Get the latest Atreca Inc (BCEL) real-time quote, historical performance, charts, and other financial information to help you make more informed …Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...

Atreca Inc. Cl A analyst ratings, historical stock prices, earnings estimates & actuals. BCEL updated stock price target summary.11.85 %. The 3 Wall Street analysts offering Atreca stock forecast in the last 6 months have average price target of $9.0 with a high forecast of $25.0 and a low forecast of $1.0. The average Atreca stock forecast represents a 3729.79% increase from the last price of $0.234999999403953. From AI system, total return is 2366.52% from 4098 forecasts.

Dec 1, 2023 · Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The Atreca stock forecast for tomorrow is $ 0.213730, which would represent a -4.16% loss compared to the current price. In the next week, the price of BCEL is expected to decrease by -24.67% and hit $ 0.167988. As far as the long-term Atreca stock forecast is concerned, here’s what our ... About the Atreca Inc – Class A stock forecast. As of 2023 November 08, Wednesday current price of BCEL stock is 0.290$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).Atreca, Inc. Class A Common Stock (BCEL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Shares in Artego SA last closed at RON15.30 and the price had moved by +23.39% over the past 365 days. In terms of relative price strength the Artego SA share price has outperformed the FTSE Global All Cap Index by +15.74% over the past year.The shares of micro-cap biotech, Atreca (BCEL +46.1%) have added more than a third in morning hours on Friday after the company updated early-stage data for its lead cancer candidate ATRC-101 with ...The above table shows the analyst BCEL forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$0.22Earnings vs Market: BCEL is forecast to remain unprofitable over the next 3 years. High Growth Earnings : BCEL is forecast to remain unprofitable over the next 3 …

BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the Aug. 7, 2023 when the stock price was at 0.91$. In the short term (2weeks), BCEL's stock price should underperform the market by -3.07%. During that period the price should oscillate between -9.61% and +7.63%.

Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now Zacks - Thu Apr 6, 8:55AM CDT . Atreca, Inc. (BCEL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall...

The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ...Find real-time KR - Kroger Co stock quotes, company profile, news and forecasts from CNN Business.According to the issued ratings of 9 analysts in the last year, the consensus rating for Hudbay Minerals stock is Moderate Buy based on the current 2 hold ratings and 7 buy ratings for HBM. The average twelve-month price prediction for Hudbay Minerals is C$9.18 with a high price target of C$10.50 and a low price target of C$8.00.The rating of the stock has changed to hold according to some analysts. It's at an all time low, buy folks thanks me later. Recently BCEL has reached an all time low and a data suggests that is will rise back up. According to Fintel.IO Blackrock has bought a staggering 350k shares. The rating of the stock has changed to hold according to some ... 🚀 Atreca stock price forecast: $4; Market Cap: 11.00M, Enterprise value: 68.43M, P/E: -0.4, PEG ratio: -0.03, EPS: -2.11, Revenue: N/A, EBITDA: -81.73M, Income ...Shares of Atreca, Inc. (. BCEL Quick Quote. BCEL - Free Report) have been struggling lately and have lost 20% over the past week. However, a hammer chart pattern was formed in its last trading ...Cymabay Therapeutics Inc () Stock Market info Recommendations: Buy or sell Cymabay Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cymabay Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Cymabay Therapeutics's CBAY shares and potentially …NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Find the latest Keurig Dr Pepper Inc. (KDP) stock quote, history, news and other vital information to help you with your stock trading and ...

The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels. How much is Atreca stock worth today? ( NASDAQ: BCEL) Atreca currently has 39,295,661 outstanding shares. With Atreca stock trading at $0.27 per share, the total value of Atreca stock (market capitalization) is $10.41M. Atreca stock was originally listed at a price of $18.05 in Jun 20, 2019.Stock Analyst Price Targets - Review. Analysts average stock forecasts to be materialized ratio is 4.17% with an average time for these price targets to be met of 0.17 days. Highest price target for BCEL is 5, Lowest price target is 1, average price target is 3. Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 14 …4/13 ratings generated profit. 31%. Average Return. -37.24%. reiterated a buy rating 10 months ago. Copying Do Kim 's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -37.24% per trade. 2 Years. dummy dummy.Instagram:https://instagram. tsla buy or sellnysearca hdvtimken conyse tef The 6 analysts offering 12-month price forecasts for Tecnoglass Inc have a median target of 50.00, with a high estimate of 56.00 and a low estimate of 45.00. The median estimate represents a +40. ... best bank in alaskabuy art shares If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti... used arc teryx The latest Atreca stock prices, stock quotes, news, and BCEL history to help you invest and trade smarter. ... The 11 analysts offering price forecasts for Atreca have a median target of 11.77 ...BCEL Stock Predictions, Articles, and Atreca Inc Cl A News From InvestorPlace From the Web 3 Penny Stocks to Catapult You Into the Millionaires’ Club By Omor Ibne Ehsan Jul 13, 2023 ...Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25.